Host cells and methods useful for producing unnatural terpenoids using a novel artificial metalloenzyme
The present invention provides for a genetically modified host cell capable of producing an unnatural compound, such as terpenoid, comprising a P450 enzyme comprising an artificial cofactor, and the host cell is capable of uptaking the artificial cofactor by comprising a heterologous heme transport transmembrane protein, or homologue thereof.
1. A genetically modified host cell capable of producing an unnatural compound, the host cell comprising:
(1) a P450 enzyme comprising an amino acid sequence at least 70% identical to SEQ ID NO:1, and W, M, Y, or C at position 256; and
(2) a heterologous heme transport transmembrane protein, or homologue thereof,
wherein the heterologous heme transport transmembrane protein in the host cell transports an artificial cofactor for uptake into the P450 enzyme.
2. The genetically modified host cell of claim 1 , wherein the P450 enzyme comprises an apo-CYP119.
3. The genetically modified host cell of claim 1 , wherein the artificial cofactor comprises a porphyrin and a metal or M(L), wherein M is a metal and L is a ligand.
4. The genetically modified host cell of claim 3 , wherein the porphyrin has the following formula:
wherein R 1a , R 1b , R 2a , R 2b , R 3a , R 3b , R 4a and R 4b are each independently selected from the group consisting of hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-8 cycloalkyl and C 6-10 aryl, wherein the alkyl is optionally substituted with —C(O)OR 5 wherein R 5 is hydrogen or C 1-6 alkyl.
5. The genetically modified host cell of claim 4 , wherein the porphyrin is pyropheophorbide-a, pheophorbide, chlorin e6, purpurin, or purpurinimide.
6. The genetically modified host cell of claim 4 , wherein the porphyrin is one selected from the group consisting of:
7. The genetically modified host cell of claim 3 , wherein the metal is a transition metal.
8. The genetically modified host cell of claim 7 , wherein the transition metal is Ir, Pd, Pt, Ag, Fe, Mn, Ru, Co, Zn, Cu, Ni, Cr, Rh or Os.
9. The genetically modified host cell of claim 7 , wherein the transition metal is Ir, Pd, Pt or Ag.
10. The genetically modified host cell of claim 3 , wherein the ligand is an alkyl, aryl, vinyl, or alkynyl.
11. The genetically modified host cell of claim 3 , wherein the artificial cofactor comprises the following structure:
wherein M is a metal, and L is an alkyl, aryl, vinyl, or alkynyl.
12. The genetically modified host cell of claim 11 , wherein the artificial cofactor comprises the following structure:
13. The genetically modified host cell of claim 11 , wherein the artificial cofactor comprises the following structure:
14. The genetically modified host cell of claim 13 , wherein the artificial cofactor comprises the following structure:
15. The genetically modified host cell of claim 1 , wherein the unnatural compound has the following structure:
wherein α and β are each independently a —H or an alkyl group, and wherein R and α may form a ring structure, R is an alkyl group comprising 3, 4, 5, 6, 7, 8, 9, 10, or more carbon atoms, optionally R comprises one or more double bonds, one or more alkyl substituents, one or more ketone substituents, and/or one or more hydroxyl substituents, optionally R comprises a cycloalkane optionally comprising one or more double bonds, one or more alkyl substituents, one or more ketone substituents, and/or one or more hydroxyl substituents.
16. The genetically modified host cell of claim 15 , wherein the unnatural compound has the following structure:
17. The genetically modified host cell of claim 15 , wherein the unnatural compound comprises a cyclopropanated pinene, linalool, nootkatone, eugenol, terpineol, polyketide, flavonoid, cannabinoid, or a compound wherein the structure (I) comprises one or more alkene.
18. The genetically modified host cell of claim 1 , wherein the P450 enzyme comprises (i) W at position 256 of SEQ ID NO: 1, (ii) M at position 256 of SEQ ID NO: 1, (iii) Y at position 256 of SEQ ID NO: 1, (iv) C at position 256 of SEQ ID NO: 1, or (v) G at position 317, G at position 213, A at position 254, W at position 155, and W at position 256 of SEQ ID NO: 1.
19. The genetically modified host cell of claim 1 , wherein the heme transport transmembrane protein comprises an amino acid sequence having at least 70% identity with SEQ ID NO:2.
20. A method for a genetically modified host cell producing an unnatural compound, comprising: (a) providing a genetically modified host cell of claim 1 , (b) introducing the artificial cofactor into the host cell, (c) culturing or growing the host cell in a suitable culture or medium such that the unnatural compound is produced, and (d) extracting or separating the unnatural compound from the rest of the culture or medium, and/or host cell.
21. The genetically modified host cell of claim 1 , wherein the P450 enzyme comprises an amino acid sequence having at least 80% identity with SEQ ID NO:1.
22. The genetically modified host cell of claim 21 , wherein the P450 enzyme comprises an amino acid sequence having at least 90% identity with SEQ ID NO:1.
23. The genetically modified host cell of claim 22 , wherein the P450 enzyme comprises an amino acid sequence having at least 95% identity with SEQ ID NO:1.
24. The genetically modified host cell of claim 23 , wherein the P450 enzyme comprises an amino acid sequence having at least 99% identity with SEQ ID NO:1.